Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
about
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerEnzyme/Prodrug Systems for Cancer Gene Therapy.Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.Non-invasive detection of bladder cancer via expression-targeted gene delivery.Anti-cancer binary system activated by bacteriophage HK022 integrase.
P2860
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@en
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@nl
type
label
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@en
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@nl
prefLabel
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@en
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@nl
P2093
P2860
P356
P1476
Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
@en
P2093
David X Liu
Jacqueline E Scapa
W T Godbey
P2860
P304
P356
10.1002/JGM.2882
P50
P577
2016-05-02T00:00:00Z